Search research articles
Contact Us
Filters
Showing results (1-10 of 85) with videos related to
Page
of 9
Sort By:
Cancer Genetics and Cytogenetics
|
January 26, 2006
The p53/Mdm2/p14ARF cell cycle control pathway genes may be inactivated by genetic and epigenetic mechanisms in gliomas
M Josefa Bello, Juan A Rey
Cancer Genetics and Cytogenetics
|
December 21, 2005
EGFR intragenic loss and gene amplification in astrocytic gliomas
Dolores Arjona, M Josefa Bello, Juan A Rey
Expert Opinion on Therapeutic Targets
|
September 21, 2012
The sonic hedgehog-GLI1 signaling pathway in brain tumor development
Mehdi H Shahi, Juan A Rey, Javier S Castresana
Molecular Biology Reports
|
July 4, 2014
Quantitative method for in vitro matrigel invasiveness measurement through image analysis software
Gabriel Gallo-Oller, Juan A Rey, Javier Dotor, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
May 19, 2010
CD133+ cells from medulloblastoma and PNET cell lines are more resistant to cyclopamine inhibition of the sonic hedgehog signaling pathway than CD133- cells
Mónica Enguita-Germán, Paula Schiapparelli, Juan A Rey, et al.
Cancer Genetics and Cytogenetics
|
September 29, 2009
cDNA microarray expression profile in vestibular schwannoma: correlation with clinical and radiological features
Luis Lassaletta, Victor Martínez-Glez, Miguel Torres-Martín, et al.
Oncology Reports
|
January 5, 2006
Promoter CpG methylation of multiple genes in pituitary adenomas: frequent involvement of caspase-8
M Josefa Bello, Jose M De Campos, Alberto Isla, et al.
Acta Neuropathologica
|
August 2, 2007
RASSF1A methylation and cyclin D1 expression in vestibular schwannomas
Luis Lassaletta, Mercedes Patrón, Teresa González, et al.
Oncology Reports
|
September 30, 2010
Analysis of stemness gene expression and CD133 abnormal methylation in neuroblastoma cell lines
Paula Schiapparelli, Mónica Enguita-Germán, Jana Balbuena, et al.
International Journal of Oncology
|
March 14, 2019
Tubastatin A, an inhibitor of HDAC6, enhances temozolomide‑induced apoptosis and reverses the malignant phenotype of glioblastoma cells
Alejandro Urdiciain, Elena Erausquin, Bárbara Meléndez, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 85) with videos related to
Sort By:
Page
of 9
Cancer Genetics and Cytogenetics
|
January 26, 2006
The p53/Mdm2/p14ARF cell cycle control pathway genes may be inactivated by genetic and epigenetic mechanisms in gliomas
M Josefa Bello, Juan A Rey
Cancer Genetics and Cytogenetics
|
December 21, 2005
EGFR intragenic loss and gene amplification in astrocytic gliomas
Dolores Arjona, M Josefa Bello, Juan A Rey
Expert Opinion on Therapeutic Targets
|
September 21, 2012
The sonic hedgehog-GLI1 signaling pathway in brain tumor development
Mehdi H Shahi, Juan A Rey, Javier S Castresana
Molecular Biology Reports
|
July 4, 2014
Quantitative method for in vitro matrigel invasiveness measurement through image analysis software
Gabriel Gallo-Oller, Juan A Rey, Javier Dotor, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
May 19, 2010
CD133+ cells from medulloblastoma and PNET cell lines are more resistant to cyclopamine inhibition of the sonic hedgehog signaling pathway than CD133- cells
Mónica Enguita-Germán, Paula Schiapparelli, Juan A Rey, et al.
Cancer Genetics and Cytogenetics
|
September 29, 2009
cDNA microarray expression profile in vestibular schwannoma: correlation with clinical and radiological features
Luis Lassaletta, Victor Martínez-Glez, Miguel Torres-Martín, et al.
Oncology Reports
|
January 5, 2006
Promoter CpG methylation of multiple genes in pituitary adenomas: frequent involvement of caspase-8
M Josefa Bello, Jose M De Campos, Alberto Isla, et al.
Acta Neuropathologica
|
August 2, 2007
RASSF1A methylation and cyclin D1 expression in vestibular schwannomas
Luis Lassaletta, Mercedes Patrón, Teresa González, et al.
Oncology Reports
|
September 30, 2010
Analysis of stemness gene expression and CD133 abnormal methylation in neuroblastoma cell lines
Paula Schiapparelli, Mónica Enguita-Germán, Jana Balbuena, et al.
International Journal of Oncology
|
March 14, 2019
Tubastatin A, an inhibitor of HDAC6, enhances temozolomide‑induced apoptosis and reverses the malignant phenotype of glioblastoma cells
Alejandro Urdiciain, Elena Erausquin, Bárbara Meléndez, et al.
Page
of 9